Abbott Laboratories (ABT) has exhibited a clear bearish trend over the past 30 days and quarter, declining sharply from levels near the 20-day SMA of 96.43 to current levels around 89.46. The price action reflects sustained selling pressure, with the stock breaking below multiple short-term moving averages and approaching its yearly low. This downtrend is characterized by lower highs and lower lows, placing ABT in oversold territory on multiple timeframes. Trading volume has been slightly elevated recently at 12.8 million shares compared to the average of 11.6 million, accompanying the downside move without significant spikes.
All moving averages for ABT are aligned bearishly, with 14 sell signals and one neutral reading. The price trades well below the 10-day SMA at 92.23, 20-day at 96.43, 50-day SMA at 104.06, 100-day SMA at 111.44, and 200-day SMA at 120.55. This configuration, including a death cross where shorter-term averages lag longer-term ones, underscores the dominant downtrend. Shorter EMAs like the 10-day at 92.72 also act as near-term resistance.
Momentum indicators for ABT show mixed but predominantly neutral-to-bearish signals amid oversold readings. The RSI(14) at 27.60 suggests the stock is oversold, potentially setting up for a short-term bounce, though it remains in sell territory. Stochastic %K (14,3,3) at 3.87 and Williams %R at -97.56 confirm deep oversold conditions. MACD (12,26) level at -3.93 generates a sell signal, with bearish divergence reinforcing downside momentum. CCI(20) at -108.25 adds to the neutral oscillator summary.
Pivot point analysis highlights critical zones for ABT. The classic pivot stands at 94.97, with support levels at S1 86.11, S2 81.43, and S3 67.88. Resistance begins at R1 99.65, followed by R2 108.52 and R3 122.06. The current price near 89.46 tests the lower range, where buyers may defend the 52-week low area around 89.14. A break below 86.11 could accelerate declines, while a hold might target initial resistance near 92-95.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns for stocks like ABT. These signals identify potential buy or sell opportunities by recognizing trends, momentum shifts, and recurring chart formations that have proven reliable over time. Traders rely on them to pinpoint entry and exit points, validate trend strength, and enhance decision-making in volatile conditions. Updated daily, the AI models adapt to evolving market dynamics, offering an objective layer to traditional analysis. Explore AI Daily Buy/Sell Signals to integrate advanced pattern recognition into your trading strategy.
Traders monitoring ABT will focus on whether oversold indicators like RSI and Stochastic lead to a reversal or if bearish MACD and moving averages drive further declines. A sustained hold above support at 86.11 could signal stabilization, with eyes on resistance at 99.65 and the pivot at 94.97 for breakout potential. Conversely, breaches below key supports may target lower pivots. Volume trends and momentum crossovers remain critical for assessing trend continuation or shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, ABT has been loosely correlated with SYK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To ABT | 1D Price Change % |
|---|---|---|
| ABT | 100% | -1.64% |
| Health Services category (247 stocks) | 14% Poorly correlated | -0.71% |
| Medical/Nursing Services category (139 stocks) | 13% Poorly correlated | -1.05% |